New genome sequencing algorithm boosts human genome completeness by 20%, improving variant detection and advancing personalized medicine.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

To prevent algorithmic bias, the authors call for multivariable modeling frameworks that jointly incorporate biological sex, genetic ancestry, and gender-related life-course exposures.

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflowData presented at AGBT ...

Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in the coming years, highlighting the increasing reliance on AI technologies ...

Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...